Oxford Global are proud to present the 14th Annual Pharmaceutical IT Congress, taking place on 28 鈥� 29 September 2016 in London, UK. This highly established event will focus on exciting Big Data implementation case studies, novel research results in translational informatics, updates in data management for Real-World Evidence and novel IT solutions.
The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Our highly anticipated event will bring together over 200 senior level experts and will provide a unique opportunity to network with representatives from leading pharmaceutical companies such as Sanofi, Novartis, Janssen, Genentech, Celgene and Pfizer. Key presentations will include case studies on IT鈥檚 tranformational approach to commercialisation and launch of a first-in-class cancer therapy by Mark McKechnie, Chief Information Officer from Merck Sharp & Dohme and Real-World Data updates by Vitalii Doban, Senior Director, Real World Data and Analytics, Pfizer.
For the latest conference updates follow us on Twitter @PharmaITConf and join the event conversation on #PharmaIT16. For more details on how to register for the meeting contact g.alonso@oxfordglobal.co.uk
The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Our highly anticipated event will bring together over 200 senior level experts and will provide a unique opportunity to network with representatives from leading pharmaceutical companies such as Sanofi, Novartis, Janssen, Genentech, Celgene and Pfizer. Key presentations will include case studies on IT鈥檚 tranformational approach to commercialisation and launch of a first-in-class cancer therapy by Mark McKechnie, Chief Information Officer from Merck Sharp & Dohme and Real-World Data updates by Vitalii Doban, Senior Director, Real World Data and Analytics, Pfizer.
For the latest conference updates follow us on Twitter @PharmaITConf and join the event conversation on #PharmaIT16. For more details on how to register for the meeting contact g.alonso@oxfordglobal.co.uk
